AL
CADX

Airain Ltd’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Airain Ltd’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,117
Closed -$110K – 971
2013
Q4 		$110K Buy
+12,117
New +$87.5K 0.01% 523

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Airain Ltd's CADX Position: Q1 2014 in Review

Airain Ltd sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 12,117 shares — an estimated $110K sold.

Airain Ltd first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $110K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Airain Ltd reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Airain Ltd sold 12,117 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $110K.
  • Airain Ltd first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Airain Ltd's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $110K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Airain Ltd's 13F filing for Q1 2014, filed 13 May 2014.